Literature DB >> 17392734

Sex difference in cognitive response to antipsychotic treatment in first episode schizophrenia.

Leah H Rubin1, Gretchen L Haas, Matcheri S Keshavan, John A Sweeney, Pauline M Maki.   

Abstract

We extend the investigation of cognitive sex differences in schizophrenia in a novel way by grouping cognitive tests according to the direction of the typical sex difference, an approach used in studies of hormonal effects on behavior in other clinical conditions. Additionally, we explore how performance on these 'male' and 'female' tests changed following antipsychotic treatment. Seventy patients with a first hospitalization for schizophrenia or schizophreniform disorder completed cognitive tests before antipsychotic treatment and approximately 5 weeks after treatment. Thirty-nine healthy comparison subjects completed the tests at similar intervals. Primary outcome variables were composite scores on cognitive tests that in normative studies favor males over females ('male' tests) or favor females over males ('female tests'). Overall, patients performed more poorly than healthy individuals. The expected pattern of sex differences was found on the composite test scores, with an advantage for females on 'female' tests and an advantage for males on 'male' tests. Female patients showed a greater improvement on 'female' tests and a decrease in performance on 'male' tests following treatment. Although male patients did not perform significantly better after treatment on 'female' tests, they did improve on non-motor 'male' tests of visuospatial skills. Future studies of the neurocognitive effects of antipsychotic treatment may need to take potential sex differences in cognitive response into account.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17392734      PMCID: PMC4394734          DOI: 10.1038/sj.npp.1301395

Source DB:  PubMed          Journal:  Neuropsychopharmacology        ISSN: 0893-133X            Impact factor:   7.853


  42 in total

1.  Sex differences in the brain.

Authors:  D Kimura
Journal:  Sci Am       Date:  1992-09       Impact factor: 2.142

2.  The global assessment scale. A procedure for measuring overall severity of psychiatric disturbance.

Authors:  J Endicott; R L Spitzer; J L Fleiss; J Cohen
Journal:  Arch Gen Psychiatry       Date:  1976-06

3.  Sex differences in olfactory function in schizophrenia.

Authors:  L Kopala; C Clark; T A Hurwitz
Journal:  Am J Psychiatry       Date:  1989-10       Impact factor: 18.112

4.  Variations in sex-related cognitive abilities across the menstrual cycle.

Authors:  E Hampson
Journal:  Brain Cogn       Date:  1990-09       Impact factor: 2.310

5.  Variation in symptom severity over the menstrual cycle of schizophrenics.

Authors:  J D Hallonquist; M V Seeman; M Lang; N A Rector
Journal:  Biol Psychiatry       Date:  1993-02-01       Impact factor: 13.382

6.  Activating effects of cross-sex hormones on cognitive functioning: a study of short-term and long-term hormone effects in transsexuals.

Authors:  D Slabbekoorn; S H van Goozen; J Megens; L J Gooren; P T Cohen-Kettenis
Journal:  Psychoneuroendocrinology       Date:  1999-05       Impact factor: 4.905

7.  Adjunctive estrogen treatment in women with chronic schizophrenia: a double-blind, randomized, and placebo-controlled trial.

Authors:  Shahin Akhondzadeh; Ali Akbar Nejatisafa; Homayoun Amini; Mohammad Reza Mohammadi; Bagher Larijani; Ladan Kashani; Firoozeh Raisi; Abbas Kamalipour
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2003-09       Impact factor: 5.067

8.  Are there gender differences in neuropsychological performance in patients with first-episode schizophrenia?

Authors:  M Albus; W Hubmann; F Mohr; J Scherer; N Sobizack; U Franz; S Hecht; M Borrmann; C Wahlheim
Journal:  Schizophr Res       Date:  1997-11-07       Impact factor: 4.939

9.  Quetiapine reduces nocturnal urinary cortisol excretion in healthy subjects.

Authors:  Stefan Cohrs; Kathrin Pohlmann; Zhenghua Guan; Wolfgang Jordan; Andreas Meier; Gerald Huether; Eckart Rüther; Andrea Rodenbeck
Journal:  Psychopharmacology (Berl)       Date:  2004-01-20       Impact factor: 4.530

10.  Sex differences in neuropsychological functioning of first-episode and chronically ill schizophrenic patients.

Authors:  A L Hoff; M Wieneke; W O Faustman; R Horon; M Sakuma; H Blankfeld; S Espinoza; L E DeLisi
Journal:  Am J Psychiatry       Date:  1998-10       Impact factor: 18.112

View more
  15 in total

1.  A closer look at siblings of patients with schizophrenia: the association of depression history and sex with cognitive phenotypes.

Authors:  Krista M Wisner; Brita Elvevåg; James M Gold; Daniel R Weinberger; Dwight Dickinson
Journal:  Schizophr Res       Date:  2010-10-28       Impact factor: 4.939

2.  A female advantage in basic face recognition is absent in schizophrenia.

Authors:  Ryan McBain; Daniel Norton; Yue Chen
Journal:  Psychiatry Res       Date:  2010-03-25       Impact factor: 3.222

3.  Effects of sex, menstrual cycle phase, and endogenous hormones on cognition in schizophrenia.

Authors:  Leah H Rubin; C Sue Carter; Lauren L Drogos; Hossein Pournajafi-Nazarloo; John A Sweeney; Pauline M Maki
Journal:  Schizophr Res       Date:  2015-05-16       Impact factor: 4.939

4.  Sex differences in human lymphoblastoid cells sensitivities to antipsychotic drugs.

Authors:  Ayelet Morag; Keren Oved; David Gurwitz
Journal:  J Mol Neurosci       Date:  2012-07-04       Impact factor: 3.444

5.  Schizophrenia is associated with dysregulation of a Cdk5 activator that regulates synaptic protein expression and cognition.

Authors:  Olivia Engmann; Tibor Hortobágyi; Ruth Pidsley; Claire Troakes; Hans-Gert Bernstein; Michael R Kreutz; Jonathan Mill; Margareta Nikolic; Karl Peter Giese
Journal:  Brain       Date:  2011-07-19       Impact factor: 13.501

6.  Sex and diagnosis specific associations between DNA methylation of the oxytocin receptor gene with emotion processing and temporal-limbic and prefrontal brain volumes in psychotic disorders.

Authors:  Leah H Rubin; Jessica J Connelly; James L Reilly; C Sue Carter; Lauren L Drogos; Hossein Pournajafi-Nazarloo; Anthony C Ruocco; Sarah K Keedy; Ian Matthew; Neeraj Tandon; Godfrey D Pearlson; Brett A Clementz; Carol A Tamminga; Elliot S Gershon; Matcheri S Keshavan; Jeffrey R Bishop; John A Sweeney
Journal:  Biol Psychiatry Cogn Neurosci Neuroimaging       Date:  2015-11-09

7.  A comparison of neuropsychological dysfunction in first-episode psychosis patients with unipolar depression, bipolar disorder, and schizophrenia.

Authors:  S Kristian Hill; James L Reilly; Margret S H Harris; Cherise Rosen; Robert W Marvin; Ovidio Deleon; John A Sweeney
Journal:  Schizophr Res       Date:  2009-05-17       Impact factor: 4.939

8.  Cognitive differences between men and women: a comparison of patients with schizophrenia and healthy volunteers.

Authors:  Julia Longenecker; Dwight Dickinson; Daniel R Weinberger; Brita Elvevåg
Journal:  Schizophr Res       Date:  2010-01-13       Impact factor: 4.939

9.  Enhanced latent inhibition in dopamine receptor-deficient mice is sex-specific for the D1 but not D2 receptor subtype: implications for antipsychotic drug action.

Authors:  Cecilie Bay-Richter; Colm M P O'Tuathaigh; Gerard O'Sullivan; David M Heery; John L Waddington; Paula M Moran
Journal:  Int J Neuropsychopharmacol       Date:  2008-11-17       Impact factor: 5.176

10.  Gender differences in neuropsychological performance across psychotic disorders--a multi-centre population based case-control study.

Authors:  Jolanta Zanelli; Kevin Morgan; Paola Dazzan; Craig Morgan; Manuela Russo; Izabela Pilecka; Paul Fearon; Arsime Demjaha; Gill A Doody; Peter B Jones; Robin M Murray; Abraham Reichenberg
Journal:  PLoS One       Date:  2013-10-28       Impact factor: 3.752

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.